NCT06999850

Brief Summary

The aim of this study is to design an instrumented test for the evaluation of the climb of stairs. In particular, the main purpose is to characterize and compare the performance of subjects, both pediatrics and adults, with different pathologies (cerebral palsy, amputee, Parkinson's disease, stroke and arthroplasty) in carrying out the instrumented test of climbing and descending stairs. This would provide potentially useful information to complement the clinical assessment, including investigating the existence of correlations between the instrumental data obtained and the clinical scales collected. The secondary objective is to evaluate, in a first phase of the study, the feasibility and reliability of the test, analyzing the validity of the indices obtained in terms of intra- and inter-operator reliability on healthy subjects.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 4, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 31, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

1 year

First QC Date

May 22, 2025

Last Update Submit

February 25, 2026

Conditions

Keywords

Stair Climb TestCerebral PalsyStrokeamputeeParkinson

Outcome Measures

Primary Outcomes (2)

  • Absolue error automatic test time

    Absolute errors were calculated for the duration time of the stair ascent and descent and for each variable by taking the absolute value after subtracting the values obtained using IMU methods from the value measured using the tradional chronometer method

    Through study completion, an average of 1 year

  • Intra - inter operator variability

    To ensure consistency between the data obtained by the IMU method and the data obtained by the traditional chronometric method, the investigators first calculated the normality of the data. The two-way mixed effects model, absolute agreement, and average measurements were used to calculate the ICCs between the duration time of both systems in case of normality. Instead, the Sperman test was used by the investigator if the data had a non-normal distribution

    Through study completion, an average of 1 year

Secondary Outcomes (4)

  • correlations with Ten meters Walk Test (10mWT)

    Through study completion, an average of 1 year

  • correlations with 30 seconds chair to stand test

    Through study completion, an average of 1 year

  • correlations with Timed Up and Go (TUG)

    Through study completion, an average of 1 year

  • correlations with Borg Scale

    Through study completion, an average of 1 year

Study Arms (8)

healthy children

OTHER

This group involves healthy children aged 4-18 years old, without gait impairmets

Other: Walk TestOther: Repaeted Instrumented Stair Climb Test

Healthy adults

OTHER

This group involves healthy adults aged 18-65 years old, without gait impairmets

Other: Walk TestOther: Repaeted Instrumented Stair Climb Test

Healthy elderly

OTHER

This group involves healthy eleferly aged 65-85 years old, without gait impairmets

Other: Walk TestOther: Repaeted Instrumented Stair Climb Test

CP subjects

OTHER

pediatric subjects diagnosed with Infantile Cerebral Paralysis (PCI) and clinical sign of left or right hemiparesis;

Other: Instrumented Stair Climb TestOther: Walk Test

Leg amputee subjects

OTHER

Patients aged 19-80 years, with results of leg amputation (transtibial), who carry limb prostheses

Other: Instrumented Stair Climb TestOther: Walk Test

Arthroplasty Subjects

OTHER

patients aged 65-80 years, with aftereffects of hip or knee arthroplasty, excluding prosthetic revision procedures

Other: Instrumented Stair Climb TestOther: Walk Test

Parkinson Subjects

OTHER

atients aged 65-80 years, with diagnosis of Parkinson's disease or Parkinsonism even on a vascular basis

Other: Instrumented Stair Climb TestOther: Walk Test

Stroke Subjects

OTHER

Patients aged 65-80 years, with aftereffects of Cerebral Stroke with left or right hemiparesis

Other: Instrumented Stair Climb TestOther: Walk Test

Interventions

Instrumented test of climbing and descending stairs for the evaluation of kinematic and electromyographic variables. The test consists of repeating the ascent and descent of a flight of 10-12 steps. In this case, the ascent and descent of the stairs must be repeated two times. Between the two trial the IMU units must be repositioned.

Healthy adultsHealthy elderlyhealthy children

Instrumented test of climbing and descending stairs for the evaluation of kinematic and electromyographic variables. The test consists of repeating the ascent and descent of a flight of 10-12 steps;

Arthroplasty SubjectsCP subjectsLeg amputee subjectsParkinson SubjectsStroke Subjects

Assessment of climbing and walking skills through test series: Borg scale: An evaluation scale for measuring effort perception. The evaluation scale consists of answering some questions at the end of the exercise described above; 10-metre walk test (10MWT): Test to assess walking speed in metres per second over a short distance. Can be used to determine functional mobility, gait and vestibular function. The test consists of walking at a steady speed and safely for 10 metres; 30 second sit to stand test: test for the evaluation of strength and endurance of the legs in the elderly. The test consists in performing the movement of standing up and sitting down from a chair for 30 consecutive seconds; Timed Up \& Go test (TUG): test to assess the risk of falling and balance. During the test, patients wear normal footwear and may use a walking aid if necessary. The patient starts in a sitting position, gets up on the therapist's command, walks in a straight line for a distance of 3 m

Arthroplasty SubjectsCP subjectsHealthy adultsHealthy elderlyLeg amputee subjectsParkinson SubjectsStroke Subjectshealthy children

Eligibility Criteria

Age4 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • \- Ability to climb and descend 10 steps with supervision, even with handrail support.

You may not qualify if:

  • Need for help from an operator or use of orthoses to make the stairs;
  • Inability to dress the instrumentation (accelerometer/electromyograph);
  • clinical condition that does not recommend the execution of scales (e.g. NYHA Class IV cardiovascular decompensation, epilepsy not controlled by drugs, serious visual disturbances...);
  • inability to follow verbal instructions.
  • age 4-80 years (8 subjects 4-18 years; 8 subjects 19-65 years; 8 subjects 65-80 years);
  • absence of diagnosis of neurological or orthopaedic pathologies, which impair the patient's mobility.
  • age range 4-18 years;
  • Diagnosis of Infantile Cerebral Palsy;
  • right or left hemiparesis;
  • ability motor skills in levels I - III according to the GMFCS (Gross Motor Function Classification System).
  • Age 65-80 years;
  • postoperative postoperative hip or knee arthroplasty (in election and post-fracture, any revisions will be excluded).
  • age range from 19 to 80 years;
  • Leg amputation (trans-tibial), fitted with limb prosthesis.
  • age range from 65 years;
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

IRCCS E. Medea

Bosisio Parini, Lecco, 23842, Italy

RECRUITING

ASP Istituti Milanesi Martinitt e Stelline e Pio Albergo Trivulzio

Milan, Milano, 20146, Italy

RECRUITING

IRCCS Istituti Clinici Maugeri Tradate

Tradate, Varese, 21049, Italy

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyStroke

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCerebrovascular DisordersVascular DiseasesCardiovascular Diseases

Central Study Contacts

Giovanni Pintabona, Medicine

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2025

First Posted

May 31, 2025

Study Start

April 4, 2025

Primary Completion

April 4, 2026

Study Completion

April 4, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Locations